rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Arye Barak Ben

General Counsel

Company insider

Files Form 4 as: General Counsel, NovoCure.

In numbers

Trades disclosed
22
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
5 Jul 2022
Last trade
30 Jun 2026
Last filed
1 Jul 2026

Companies traded

Where they are an officer
NVCR NovoCureOfficer · Medical Devices · last 30 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 1 Jul 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A$14K1,299 at $11.15filing
30 Jun 2026filed 1 Jul 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A$14K1,299 at $11.15filing
3 Mar 2026filed 5 Mar 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A—50,125 at $0.00filing
3 Mar 2026filed 5 Mar 2026NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A—73,340 at $0.00filing
3 Mar 2026filed 5 Mar 2026NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A—73,340 at $0.00filing
3 Mar 2026filed 5 Mar 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A—50,125 at $0.00filing
28 Feb 2026filed 3 Mar 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A—17,755 at $0.00filing
28 Feb 2026filed 3 Mar 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A—17,755 at $0.00filing
31 Dec 2025filed 8 Jan 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A$1,187108 at $10.99filing
30 Jun 2025filed 1 Jul 2025NVCR NovoCureMedical DevicesSEC FORM 4 Code A$12K769 at $15.13filing
4 Mar 2025filed 6 Mar 2025NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A$1.5M81,499 at $18.19filing
4 Mar 2025filed 6 Mar 2025NVCR NovoCureMedical DevicesSEC FORM 4 Code A$1000K54,975 at $18.19filing
31 Dec 2024filed 3 Jan 2025NVCR NovoCureMedical DevicesSEC FORM 4 Code A$9,868669 at $14.75filing
28 Jun 2024filed 6 Aug 2024NVCR NovoCureMedical DevicesSEC FORM 4 Code A$11K930 at $12.24filing
27 Feb 2024filed 29 Feb 2024NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A$2.0M125,078 at $16.30filing
27 Feb 2024filed 29 Feb 2024NVCR NovoCureMedical DevicesSEC FORM 4 Code A$1.3M81,799 at $16.30filing
31 Dec 2023filed 29 Feb 2024NVCR NovoCureMedical DevicesSEC FORM 4 Code A$1,624128 at $12.69filing
30 Jun 2023filed 6 Jul 2023NVCR NovoCureMedical DevicesSEC FORM 4 Code A$10K288 at $35.28filing
28 Feb 2023filed 2 Mar 2023NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A$2.3M29,531 at $76.97filing
28 Feb 2023filed 2 Mar 2023NVCR NovoCureMedical DevicesSEC FORM 4 Code A—17,755 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Asaf DanzigerDirector · Director at NovoCure, filing Form 4 there in the last year
Michal Nath PuriChief Human Resources Officer · Chief Human Resources Officer at NovoCure, filing Form 4 there in the last year
Frank X. LeonardChief Executive Officer · Chief Executive Officer at NovoCure, filing Form 4 there in the last year
W. Anthony VernonDirector · Director at NovoCure, filing Form 4 there in the last year
Allyson J. OceanDirector · Director at NovoCure, filing Form 4 there in the last year